While Uttar Pradesh has sought 10 million doses (five million each from Serum Institute and Bharat Biotech), Maharashtra is looking to procure 15 million and is floating a global tender for this. Vaccine makers, however, say states are seeking to procure the products at Rs 150 per dose after the Centre said it would continue to get them at that price.
However, Maharashtra is yet to firm up its views on free doses. While Maharashtra Health Minister Rajesh Tope had earlier ruled out free vaccination for all, Minority Affairs Minister Nawab Malik indicated on Sunday the government would give free doses to residents in Maharashtra.
States would have to fund procurement from their own budgets and bridge funding from the Centre is unlikely. “As of now we estimate that the state will have to spend around Rs 5,000 crore on procuring vaccines. We will negotiate prices with vaccine manufacturers and try to get them at a lower price than the one declared by them,” said a Maharashtra government official.
States have, nonetheless, started indicating their immediate requirements to vaccine makers. Most states have formed high-level committees comprising ministers and bureaucrats who will decide on the number of beneficiaries, expenditure on free vaccination drive, pricing strategy, etc.
West Bengal health department officials said the mode of procurement for the 18-44 age group was under discussion. “Discussions are being held at every level,” one of them said.
The Ministry of Health and Family Welfare has said it would continue to buy the two vaccines – Covishield and Covaxin – at Rs 150 per dose. The Centre will supply the doses it supplies states for free. The Centre will continue to pick up the tab for those above 45 years if they visit a government hospital or vaccination centre for the jab. States have to procure for those above 18 and citizens also have the option to pay for a shot in a private hospital.
Both companies have announced the prices at which private hospitals can buy the vaccines — Rs 600 (Covishield) and Rs 1,200 (Covaxin).
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)